Header Logo

Connection

VALERIA SMITH to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications VALERIA SMITH has written about Xenograft Model Antitumor Assays.
VALERIA SMITH
Connection Strength
0.027
Xenograft Model Antitumor Assays
  1. The novel kinase inhibitor ponatinib is an effective anti-angiogenic agent against neuroblastoma. Invest New Drugs. 2016 12; 34(6):685-692.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.